The multifaceted impact of DNMT1 across various signaling pathways and cellular mechanisms underlines its potential as a critical target in future prostate cancer treatments, particularly in strategies aimed at overcoming metastasis and resistance to conventional therapies. The gene discussed is DNMT1; the disease is prostate carcinoma.